The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained
- PMID: 34455081
- PMCID: PMC8444629
- DOI: 10.1016/j.ijid.2021.08.060
The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained
Abstract
Objectives: Streptococcus pneumoniae is the leading bacterial pathogen causing respiratory infections. Since the COVID-19 pandemic emerged, less invasive pneumococcal disease (IPD) was identified by surveillance systems worldwide. Measures to prevent transmission of SARS-CoV-2 also reduce transmission of pneumococci, but this would gradually lead to lower disease rates.
Design: Here, we explore additional factors contributing to the instant drop in pneumococcal disease cases captured in surveillance.
Results: Our observations on referral practices and other impediments to diagnostic testing indicate that residual IPD has likely occurred but remained undetected by conventional hospital-based surveillance.
Conclusions: Depending on the setting, we discuss alternative monitoring strategies that could improve understanding of pneumococcal disease dynamics.
Keywords: COVID-19; IPD; Pandemic; S. pneumoniae; Surveillance.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Figures
References
-
- Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4(3):144–154. - PubMed
-
- Brueggemann AB, Jansen van Rensburg MJ, Shaw D, McCarthy ND, Jolley KA, Maiden MCJ. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3(6):e360–ee70. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
